CYP3A4型
等位基因
决奈达隆
微粒体
细胞色素P450
同工酶
生物
野生型
药物代谢
人口
遗传学
药理学
酶
体外
生物化学
基因
医学
内科学
突变体
胺碘酮
环境卫生
心房颤动
作者
Chenchen Wang,Tian Lan
出处
期刊:Current Drug Metabolism
[Bentham Science]
日期:2022-06-01
卷期号:23 (7): 562-570
标识
DOI:10.2174/1389200223666220613153917
摘要
Cytochrome P450 (P450) is the largest family of enzymatic proteins in the human liver, and its features have been studied in physiology, medicine, biotechnology, and phytoremediation.The aim of this study was to assess the catalytic activities of 28 human CYP3A4 alleles by using dronedarone as a probe drug in vitro, including 7 novel alleles recently found in the Han Chinese population.We expressed 28 CYP3A4 alleles in insect microsomes and incubated them with 1-100 μM of dronedarone at 37 °C for 40 minutes to obtain the metabolites of N-debutyl-dronedarone.Compared with the wild type of CYP3A4, the 27 defective alleles can be classified into four categories. Three alleles had no detectable enzyme activity leading to a lack of kinetic parameters of N-debutyl-dronedarone; the other three alleles slightly despaired when it comes to intrinsic clearance values compared with the features of the wild type. Sixteen alleles exhibited 35.91%~79.70% relative values (in comparison to the wild-type) and could be defined as the "moderate decrease group". The rest of the alleles showed a considerable decrease in intrinsic clearance values, ranging from 11.88%~23.34%. Therefore they were classified as a "significantly decreased group". More specifically, 18 CYP3A4 alleles exhibited a substrate inhibition trend toward dronedarone when the concentration rises to 20 μM.The outcomes of this novel study on the metabolism of dronedarone by CYP3A4 alleles can be used as experimental data support for the individualized use of this modern drug.
科研通智能强力驱动
Strongly Powered by AbleSci AI